Skip to main content

Table 2 Baseline characteristics from participants of the online questionnaire

From: Patient involvement to inform the design of a clinical trial in postbariatric hypoglycaemia

Characteristic Median (IQR; range) n (%)
Total   29 (100%)
Age 40.45 (IQR 31–51.5; 20–57)  
Sex
 male   2 (6.9%)
 female   17 (58.6%)
 no response   10 (34.4%)
Type of surgery
 Roux-Y gastric bypass   18 (62.1%)
 sleeve gastrectomy   1 (3.4%)
 others   1 (3.4%)
 no response   9 (31.0%)
Duration since bariatric surgery (years) 5 (IQR 2.8–7; range 1–9)  
Number of hypoglycemic episodes per week
 daily   5 (17.2%)
 not daily, but several days a week   10 (34.5%)
 not weekly, but at least once a month   5 (17.2%)
 no response   9 (31.0%)
Patients receiving off-label drug therapy
 yes   9 (31.0%)
 no   11 (37.9%)
 no response   9 (31.0%)
Type of off-label therapy for postbariatric hypoglycemia
 acarbose   2
 liraglutide   2
 empagliflozin   2
 octreotide   1
 onglyza   1